Effect of targeted estrogen delivery using glucagon-like peptide-1 on insulin secretion, insulin sensitivity and glucose homeostasis

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Tiano, Joseph P ^b   Tate, Chandra R ^a   Yang, Bin S ^c   Dimarchi, Richard ^c   Mauvais Jarvis, Franck ^a,b  

^a TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG CARRIER; ESTROGEN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN;

ANIMAL; BODY COMPOSITION; CELL CULTURE TECHNIQUE; DRUG DELIVERY SYSTEM; DRUG EFFECTS; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; MIDDLE AGED; MOUSE; PANCREAS ISLET; PANCREAS ISLET BETA CELL;

ANIMALS; BODY COMPOSITION; CELL CULTURE TECHNIQUES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ESTROGENS; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MALE; MICE; MIDDLE AGED;

EID: 84929331327     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10211     Document Type: Article

References (29)

1. Deroo, B. J. & Korach, K. S. Estrogen receptors and human disease. J. Clin. Invest. 116, 561-570 (2006).
2. Alonso-Magdalena, P., et al. Pancreatic insulin content regulation by the estrogen receptor ER alpha. PLoS One 3, e2069 (2008).
3. Contreras, J. L., et al. 17beta-Estradiol protects isolated human pancreatic islets against proinflammatory cytokine-induced cell death: molecular mechanisms and islet functionality. Transplantation 74, 1252-1259. (2002).
4. Kilic, G., et al. The islet estrogen receptor-alpha is induced by hyperglycemia and protects against oxidative stress-induced insulin-deficient diabetes. PLoS One 9, e87941 (2014).
5. Le May, C., et al. Estrogens protect pancreatic beta-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice. Proc. Natl. Acad. Sci. USA 103, 9232-9237 (2006).
6. Liu, S., et al. Oestrogens improve human pancreatic islet transplantation in a mouse model of insulin deficient diabetes. Diabetologia 56, 370-381 (2013).
7. Liu, S., et al. Importance of extranuclear estrogen receptor-alpha and membrane G protein-coupled estrogen receptor in pancreatic islet survival. Diabetes 58, 2292-2302 (2009).
8. Tiano, J. P., et al. Estrogen receptor activation reduces lipid synthesis in pancreatic islets and prevents beta cell failure in rodent models of type 2 diabetes. J. Clin. Invest. 121, 3331-3342 (2011).
9. Tiano, J. P. & Mauvais-Jarvis, F. Importance of oestrogen receptors to preserve functional beta-cell mass in diabetes. Nat. Rev. Endocrinol 8, 342-351 (2012).
10. Wong, W. P., et al. Extranuclear estrogen receptor-{alpha} stimulates NeuroD1 binding to the insulin promoter and favors insulin synthesis. Proc. Natl. Acad. Sci. USA 107, 13057-62 (2010).
11. Margolis, K. L., et al. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 47, 1175-1187 (2004).
12. Kanaya, A. M., et al. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 138, 1-9 (2003).
13. Mauvais-Jarvis, F., Clegg, D. J. & Hevener, A. L. The Role of Estrogens in Control of Energy Balance and Glucose Homeostasis. Endocr. Rev. 34: 309-38 (2013).
14. Barrera, J. G., Sandoval, D. A., D'Alessio, D. A. & Seeley, R. J. GLP-1 and energy balance: an integrated model of short-term and long-term control. Nat. Rev. Endocrinol 7, 507-516 (2011).
15. Drucker, D. J. The biology of incretin hormones. Cell Metab. 3, 153-165 (2006).
16. Finan, B., et al. Targeted estrogen delivery reverses the metabolic syndrome. Nat. Med. 18, 1847-1856 (2012).
17. Schwenk, R. W., et al. GLP-1-oestrogen attenuates hyperphagia and protects from beta cell failure in diabetes-prone New Zealand obese (NZO) mice. Diabetologia 58, 604-14 (2014).
18. Baquie, M., et al. The liver receptor homolog-1 (LRH-1) is expressed in human islets and protects {beta}-cells against stressinduced apoptosis. Hum. Mol. Genet. 20, 2823-2833 (2011).
19. Shupnik, M. A., Gordon, M. S. & Chin, W. W. Tissue-specific regulation of rat estrogen receptor mRNAs. Mol. Endocrinol 3, 660-665 (1989).
20. Lee, S., et al. Comparison between surrogate indexes of insulin sensitivity and resistance and hyperinsulinemic euglycemic clamp estimates in mice. Am. J. Physiol. Endocrinol Metab. 294 E261-270 (2008).
21. Sharma, G. & Prossnitz, E. R. Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic beta-cells. Endocrinology 152, 3030-3039 (2011).
22. Soriano, S., et al. Rapid regulation of K(ATP) channel activity by 17{beta}-estradiol in pancreatic {beta}-cells involves the estrogen receptor {beta} and the atrial natriuretic peptide receptor. Mol. Endocrinol 23, 1973-1982 (2009).
23. Ding, X., et al. Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice. Hepatology 43, 173-181 (2006).
24. Kim, J. H., et al. Tissue-selective estrogen complexes with bazedoxifene prevent metabolic dysfunction in female mice. Mol. Metab. 3, 177-190 (2014).
25. Zhu, L., et al. Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance. Diabetes 62, 424-434 (2013).
26. Ahmed-Sorour, H. & Bailey, C. J. Role of ovarian hormones in the long-term control of glucose homeostasis. Interaction with insulin, glucagon and epinephrine. Horm. Res. 13, 396-403 (1980).
27. Lee, Y. S., et al. Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis. Diabetes 56, 1671-1679 (2007).
28. Zhu, L., et al. Estrogen signaling prevents diet-induced hepatic insulin resistance in male mice with obesity. Am. J. Physiol. Endocrinol Metab. 306, E1188-1197 (2014).
29. Burmeister, M. A., et al. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice. Am. J. Physiol. Endocrinol Metab. 302 E334-343 (2012).